SCHEMBL8536963

SCHEMBL8536963

C[C@]12CC[C@H]3[C@@H](CCC4CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2C(=O)Sc1ccccn1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B10 O60218 3/20 0.61
AKR1B1 P15121 3/20 0.61
GPBAR1 Q8TDU6 3/20 0.61
CYP19A1 P11511 6/20 0.53
SHBG P04278 3/20 0.53
NR3C1 P04150 1/20 0.53
PGR P06401 1/20 0.53
SERPINA6 P08185 1/20 0.53
NR3C2 P08235 1/20 0.53
CYP3A4 P08684 1/20 0.53
AR P10275 1/20 0.53
HSD17B10 Q99714 1/20 0.53
MGAM O43451 1/20 0.53
POLB P06746 1/20 0.47
MAPK1 P28482 1/20 0.47
CYP17A1 P05093 1/20 0.47
OR51E2 Q9H255 1/20 0.47
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
KDM4E B2RXH2 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7622722 0.83 SRD5A2 (0.61) AR
SCHEMBL8795547 0.83 SRD5A1 (0.56)
SCHEMBL8633690 0.79 LMNA (0.63) GPBAR1CYP19A1SHBGNR3C1PGR
SCHEMBL9570930 0.79 SRD5A1 (0.43)
SCHEMBL9318810 0.79 SRD5A1 (0.43)
SCHEMBL13611186 0.78 SRD5A2 (0.44) AKR1B10AKR1B1GPBAR1AR
SCHEMBL13603626 0.78 SRD5A2 (0.44) AKR1B10AKR1B1GPBAR1AR
SCHEMBL8409235 0.78 SRD5A1 (0.63)
SCHEMBL7621779 0.78 SRD5A1 (0.63)
SCHEMBL23699767 0.77 AKR1B10 (1.00) AKR1B10AKR1B1GPBAR1CYP19A1SHBG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5760045-A BENIGN PROSTATIC HYPERPLASIA MERCK & CO., INC. (US) 1998-06-02 US disclosed
US-5710275-A ENZYME AND HORMONE INHIBITORS MERCK & CO., INC. (US) 1998-01-20 US disclosed
US-5693809-A PREGNANES FOR TREATING ALOPECIA, ACNE AND SKIN DISORDER MERCK & CO., INC. (US) 1997-12-02 US disclosed
EP-0646007-B1 NEW DELTA-17 AND DELTA-20 OLEFINIC AND SATURATED 17$g(b)-SUBSTITUTED-4-AZA-5$g(a)-ANDROSTAN-3-ONES AS 5$g(a)-REDUCTASE INHIBITORS MERCK & CO INC (US) 1997-08-13 EP disclosed
EP-0778284-A2 New 7-beta-substituted-4-aza-5alpha-androstan-3-ones as 5alpha-reductase inhibitors MERCK & CO. INC. (US) 1997-06-11 EP disclosed
US-5510351-A PREGNANE ENZYME INHIBITOR FOR TREATING SKIN DISORDER, BALDNESS, PROSTATIC CANCER MERCK & CO., INC. (US) 1996-04-23 US disclosed
EP-0646007-A4 1995-04-26 EP disclosed
EP-0646007-A1 NEW DELTA-17 AND DELTA-20 OLEFINIC AND SATURATED 17-g(b)-SUBSTITUTED-4-AZA-5-g(a)-ANDROSTAN-3-ONES AS 5-g(a)-REDUCTASE INHIBITORS. MERCK & CO INC (US) 1995-04-05 EP disclosed
EP-0572166-A1 New 7beta-substituted-4-aza-5a-androstan-3-ones as 5a-reductase inhibitors MERCK & CO. INC. (US) 1993-12-01 EP disclosed
WO-1993023050-A1 NEW DELTA-17 AND DELTA-20 OLEFINIC AND SATURATED 17β-SUBSTITUTED-4-AZA-5α-ANDROSTAN-3-ONES AS 5α-REDUCTASE INHIBITORS MERCK & CO., INC. (US) 1993-11-25 WO disclosed